{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:54:31Z","timestamp":1778806471876,"version":"3.51.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:00:00Z","timestamp":1725494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:00:00Z","timestamp":1725494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Japan Sports Agency Ministry of Education, Culture, Sports, Science and Technology-Japan","award":["Research and Development Project on Anti-doping Science"],"award-info":[{"award-number":["Research and Development Project on Anti-doping Science"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-71851-z","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T08:05:51Z","timestamp":1725609951000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A randomized placebo controlled trial demonstrates the effect of dl-methylephedrine on brain functions is weaker than that of pseudoephedrine"],"prefix":"10.1038","volume":"14","author":[{"given":"Takeshi","family":"Sakayori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumiko","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryosuke","family":"Arakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Nogami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amane","family":"Tateno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,5]]},"reference":[{"key":"71851_CR1","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jsams.2010.09.001","volume":"14","author":"C Chiamulera","year":"2011","unstructured":"Chiamulera, C. Research is needed on the use of cognitive enhancer drugs in sport. J. Sci. Med. Sport. 14, 2\u20133 (2011).","journal-title":"J. Sci. Med. Sport."},{"key":"71851_CR2","unstructured":"World Anti-Doping Agency. World anti-doping code: Prohibited list 2024. https:\/\/www.wada-ama.org\/sites\/default\/files\/2023-09\/2024list_en_final_22_september_2023.pdf (2024)."},{"key":"71851_CR3","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.ejphar.2015.07.044","volume":"764","author":"I Dela Pena","year":"2015","unstructured":"Dela Pena, I., Gevorkiana, R. & Shi, W. Psychostimulants affect dopamine transmission through both dopamine transporter-dependent and independent mechanisms. Eur. J. Pharmacol. 764, 562\u2013570 (2015).","journal-title":"Eur. J. Pharmacol."},{"key":"71851_CR4","doi-asserted-by":"publisher","first-page":"806","DOI":"10.3389\/fphar.2020.00806","volume":"11","author":"B Loi","year":"2020","unstructured":"Loi, B., Sahai, M. A., De Luca, M. A., Shiref, H. & Opacka-Juffry, J. The role of dopamine in the stimulant characteristics of novel psychoactive substances (NPS)-neurobiological and computational assessment using the case of desoxypipradrol (2-DPMP). Front. Pharmacol. 11, 806 (2020).","journal-title":"Front. Pharmacol."},{"key":"71851_CR5","doi-asserted-by":"publisher","first-page":"552","DOI":"10.3928\/0090-4481-20060801-07","volume":"35","author":"LL Greenhill","year":"2006","unstructured":"Greenhill, L. L. The science of stimulant abuse. Pediatr. Ann. 35, 552\u2013556 (2006).","journal-title":"Pediatr. Ann."},{"key":"71851_CR6","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.neuropharm.2015.01.013","volume":"93","author":"LM McFadden","year":"2015","unstructured":"McFadden, L. M., Vieira-Brock, P. L., Hanson, G. R. & Fleckenstein, A. E. Prior methamphetamine self-administration attenuates the dopaminergic deficits caused by a subsequent methamphetamine exposure. Neuropharmacology. 93, 146\u2013154 (2015).","journal-title":"Neuropharmacology."},{"key":"71851_CR7","doi-asserted-by":"publisher","first-page":"5575","DOI":"10.1523\/JNEUROSCI.4050-13.2014","volume":"34","author":"CA Siciliano","year":"2014","unstructured":"Siciliano, C. A., Calipari, E. S., Ferris, M. J. & Jones, S. R. Biphasic mechanisms of amphetamine action at the dopamine terminal. J. Neurosci. 34, 5575\u20135582 (2014).","journal-title":"J. Neurosci."},{"key":"71851_CR8","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1093\/jat\/27.6.359","volume":"27","author":"YL Tseng","year":"2003","unstructured":"Tseng, Y. L., Hsu, H. R., Kuo, F. H., Shieh, M. H. & Chang, C. F. Ephedrines in over-the-counter cold medicines and urine specimens collected during sport competitions. J. Anal. Toxicol. 27, 359\u2013365 (2003).","journal-title":"J. Anal. Toxicol."},{"key":"71851_CR9","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1365-2125.1978.tb04588.x","volume":"6","author":"CD Drew","year":"1978","unstructured":"Drew, C. D., Knight, G. T., Hughes, D. T. & Bush, M. Comparison of the effects of D-(-)-ephedrine and L-(+)-pseudoephedrine on the cardiovascular and respiratory systems in man. Br. J. Clin. Pharmacol. 6, 221\u2013225 (1978).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"71851_CR10","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1249\/01.mss.0000183201.79330.9c","volume":"38","author":"K Hodges","year":"2006","unstructured":"Hodges, K., Hancock, S., Currell, K., Hamilton, B. & Jeukendrup, A. E. Pseudoephedrine enhances performance in 1500-m runners. Med. Sci. Sports Exerc. 38, 329\u2013333 (2006).","journal-title":"Med. Sci. Sports Exerc."},{"key":"71851_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/bmjsem-2015-000066","volume":"1","author":"KV Trinh","year":"2015","unstructured":"Trinh, K. V., Kim, J. & Ritsma, A. Effect of pseudoephedrine in sport: A systematic review. BMJ Open Sport Exerc. Med. 1, e000066 (2015).","journal-title":"BMJ Open Sport Exerc. Med."},{"key":"71851_CR12","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s40798-018-0159-7","volume":"4","author":"MD Gheorghiev","year":"2018","unstructured":"Gheorghiev, M. D., Hosseini, F., Moran, J. & Cooper, C. E. Effects of pseudoephedrine on parameters affecting exercise performance: A meta-analysis. Sports Med. Open. 4, 44 (2018).","journal-title":"Sports Med. Open."},{"key":"71851_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.799319","volume":"13","author":"T Nogami","year":"2022","unstructured":"Nogami, T., Arakawa, R., Sakayori, T. & Ikeda, Y. Effect of DL-methylephedrine on dopamine transporter using positron emission tomography with [18F]FE-PE2I. Front. Psychiatry. 13, 799319 (2022).","journal-title":"Front. Psychiatry."},{"key":"71851_CR14","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.2967\/jnumed.111.101626","volume":"53","author":"T Sasaki","year":"2012","unstructured":"Sasaki, T. et al. Quantification of dopamine transporter in human brain using PET with 18F-FE-PE2I. J. Nucl. Med. 53, 1065\u20131073 (2012).","journal-title":"J. Nucl. Med."},{"key":"71851_CR15","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1002\/syn.20670","volume":"63","author":"A Varrone","year":"2009","unstructured":"Varrone, A. et al. In vitro autoradiography and in vivo evaluation in cynomolgus monkey of [18F]FE-PE2I, a new dopamine transporter PET radioligand. Synapse. 63, 871\u2013880 (2009).","journal-title":"Synapse."},{"key":"71851_CR16","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1017\/S1461145713001612","volume":"17","author":"W Kim","year":"2014","unstructured":"Kim, W. et al. In vivo activity of modafinil on dopamine transporter measured with positron emission tomography and [(1)(8)F]FE-PE2I. Int. J. Neuropsychopharmacol. 17, 697\u2013703 (2014).","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"71851_CR17","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1007\/s00213-013-3392-2","volume":"231","author":"T Sakayori","year":"2014","unstructured":"Sakayori, T. et al. Effect of mazindol on extracellular dopamine concentration in human brain measured by PET. Psychopharmacology (Berl). 231, 2321\u20132325 (2014).","journal-title":"Psychopharmacology (Berl)."},{"key":"71851_CR18","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/nrn730","volume":"3","author":"DJ Heeger","year":"2002","unstructured":"Heeger, D. J. & Ress, D. What does fMRI tell us about neuronal activity?. Nat. Rev. Neurosci. 3, 142\u2013151 (2002).","journal-title":"Nat. Rev. Neurosci."},{"key":"71851_CR19","doi-asserted-by":"publisher","first-page":"9868","DOI":"10.1073\/pnas.87.24.9868","volume":"87","author":"S Ogawa","year":"1990","unstructured":"Ogawa, S., Lee, T. M., Kay, A. R. & Tank, D. W. Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proc. Natl. Acad. Sci. U. S. A. 87, 9868\u20139872 (1990).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"71851_CR20","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/nn.2510","volume":"13","author":"JW Buckholtz","year":"2010","unstructured":"Buckholtz, J. W. et al. Mesolimbic dopamine reward system hypersensitivity in individuals with psychopathic traits. Nat. Neurosci. 13, 419\u2013421 (2010).","journal-title":"Nat. Neurosci."},{"key":"71851_CR21","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.1007\/s00213-014-3499-0","volume":"231","author":"T Funayama","year":"2014","unstructured":"Funayama, T. et al. Modafinil augments brain activation associated with reward anticipation in the nucleus accumbens. Psychopharmacology (Berl). 231, 3217\u20133228 (2014).","journal-title":"Psychopharmacology (Berl)."},{"key":"71851_CR22","doi-asserted-by":"publisher","first-page":"3655","DOI":"10.1007\/s00213-019-05337-6","volume":"236","author":"Y Ikeda","year":"2019","unstructured":"Ikeda, Y. et al. Bupropion increases activation in nucleus accumbens during anticipation of monetary reward. Psychopharmacology (Berl). 236, 3655\u20133665 (2019).","journal-title":"Psychopharmacology (Berl)."},{"key":"71851_CR23","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.neuroimage.2007.09.011","volume":"39","author":"H Ito","year":"2008","unstructured":"Ito, H., Takahashi, H., Arakawa, R., Takano, H. & Suhara, T. Normal database of dopaminergic neurotransmission system in human brain measured by positron emission tomography. Neuroimage. 39, 555\u2013565 (2008).","journal-title":"Neuroimage."},{"key":"71851_CR24","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1006\/nimg.1998.0366","volume":"9","author":"H Hall","year":"1999","unstructured":"Hall, H. et al. Visualization of the dopamine transporter in the human brain postmortem with the new selective ligand [125I]PE2I. Neuroimage. 9, 108\u2013116 (1999).","journal-title":"Neuroimage."},{"key":"71851_CR25","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.biopsych.2007.07.023","volume":"63","author":"B Knutson","year":"2008","unstructured":"Knutson, B., Bhanji, J. P., Cooney, R. E., Atlas, L. Y. & Gotlib, I. H. Neural responses to monetary incentives in major depression. Biol. Psychiatry. 63, 686\u2013692 (2008).","journal-title":"Biol. Psychiatry."},{"key":"71851_CR26","doi-asserted-by":"publisher","first-page":"3398","DOI":"10.1002\/hbm.24184","volume":"39","author":"S Oldham","year":"2018","unstructured":"Oldham, S. et al. The anticipation and outcome phases of reward and loss processing: A neuroimaging meta-analysis of the monetary incentive delay task. Hum. Brain Mapp. 39, 3398\u20133418 (2018).","journal-title":"Hum. Brain Mapp."},{"key":"71851_CR27","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1007\/s11065-018-9385-5","volume":"28","author":"RP Wilson","year":"2018","unstructured":"Wilson, R. P. et al. The neural substrate of reward anticipation in health: A meta-analysis of fMRI findings in the monetary incentive delay task. Neuropsychol. Rev. 28, 496\u2013506 (2018).","journal-title":"Neuropsychol. Rev."},{"key":"71851_CR28","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1176\/ajp.155.10.1325","volume":"155","author":"ND Volkow","year":"1998","unstructured":"Volkow, N. D. et al. Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am. J. Psychiatry. 155, 1325\u20131331 (1998).","journal-title":"Am. J. Psychiatry."},{"key":"71851_CR29","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s00213-016-4464-x","volume":"234","author":"Y Kimura","year":"2017","unstructured":"Kimura, Y. et al. Measurement of psychological state changes at low dopamine transporter occupancy following a clinical dose of mazindol. Psychopharmacology (Berl). 234, 323\u2013328 (2017).","journal-title":"Psychopharmacology (Berl)."},{"key":"71851_CR30","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jad.2005.08.016","volume":"89","author":"M Argyelan","year":"2005","unstructured":"Argyelan, M. et al. Dopamine transporter availability in medication free and in bupropion treated depression: A 99mTc-TRODAT-1 SPECT study. J. Affect. Disord. 89, 115\u2013123 (2005).","journal-title":"J. Affect. Disord."},{"key":"71851_CR31","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/386827a0","volume":"386","author":"ND Volkow","year":"1997","unstructured":"Volkow, N. D. et al. Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature. 386, 827\u2013830 (1997).","journal-title":"Nature."},{"key":"71851_CR32","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1124\/pr.112.007054","volume":"66","author":"S Wood","year":"2014","unstructured":"Wood, S., Sage, J. R., Shuman, T. & Anagnostaras, S. G. Psychostimulants and cognition: A continuum of behavioral and cognitive activation. Pharmacol. Rev. 66, 193\u2013221 (2014).","journal-title":"Pharmacol. Rev."},{"key":"71851_CR33","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.neuron.2004.06.030","volume":"43","author":"B Knutson","year":"2004","unstructured":"Knutson, B. et al. Amphetamine modulates human incentive processing. Neuron. 43, 261\u2013269 (2004).","journal-title":"Neuron."},{"key":"71851_CR34","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1093\/jat\/22.4.310","volume":"22","author":"G Kunsman","year":"1998","unstructured":"Kunsman, G., Jones, R., Levine, B. & Smith, M. Methylephedrine concentrations in blood and urine specimens. J. Anal. Toxicol. 22, 310\u2013313 (1998).","journal-title":"J. Anal. Toxicol."},{"key":"71851_CR35","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/dta.1803","volume":"8","author":"A Kojima","year":"2016","unstructured":"Kojima, A. et al. Comparison of urine analysis and dried blood spot analysis for the detection of ephedrine and methylephedrine in doping control. Drug Test Anal. 8, 189\u2013198 (2016).","journal-title":"Drug Test Anal."},{"key":"71851_CR36","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/MNM.0000000000000052","volume":"35","author":"M Suzuki","year":"2014","unstructured":"Suzuki, M. et al. Reproducibility of PET measurement for presynaptic dopaminergic functions using L-[beta-(11)C]DOPA and [(18)F]FE-PE2I in humans. Nucl. Med. Commun. 35, 231\u2013237 (2014).","journal-title":"Nucl. Med. Commun."},{"key":"71851_CR37","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1038\/sj.npp.1301534","volume":"33","author":"MJ Minzenberg","year":"2008","unstructured":"Minzenberg, M. J. & Carter, C. S. Modafinil: A review of neurochemical actions and effects on cognition. Neuropsychopharmacology. 33, 1477\u20131502 (2008).","journal-title":"Neuropsychopharmacology."},{"key":"71851_CR38","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.biopsych.2009.12.015","volume":"67","author":"JW Young","year":"2010","unstructured":"Young, J. W. & Geyer, M. A. Action of modafinil\u2013increased motivation via the dopamine transporter inhibition and D1 receptors?. Biol. Psychiatry. 67, 784\u2013787 (2010).","journal-title":"Biol. Psychiatry."},{"key":"71851_CR39","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40798-021-00374-y","volume":"8","author":"J Berezanskaya","year":"2022","unstructured":"Berezanskaya, J., Cade, W., Best, T. M., Paultre, K. & Kienstra, C. ADHD prescription medications and their effect on athletic performance: A systematic review and meta-analysis. Sports Med. Open. 8, 5 (2022).","journal-title":"Sports Med. Open."},{"issue":"Suppl 2","key":"71851_CR40","doi-asserted-by":"publisher","first-page":"S175","DOI":"10.1007\/s40279-014-0257-8","volume":"44","author":"LL Spriet","year":"2014","unstructured":"Spriet, L. L. Exercise and sport performance with low doses of caffeine. Sports Med. 44(Suppl 2), S175-184 (2014).","journal-title":"Sports Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71851-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71851-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71851-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T08:10:53Z","timestamp":1725610253000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71851-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,5]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["71851"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-71851-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,5]]},"assertion":[{"value":"29 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20793"}}